From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease

Author:

Hagmeyer Lars123ORCID,van Koningsbruggen‐Rietschel Silke43,Matthes Sandhya2,Rietschel Ernst43,Randerath Winfried123

Affiliation:

1. Institute of Pneumology at the University of Cologne Solingen Germany

2. Clinic for Pneumology and Allergology, Center of Sleep Medicine and Respiratory Care, Bethanien Hospital Solingen Solingen Germany

3. Center for Rare Diseases, Faculty of Medicine University of Cologne, Children's Hospital Cologne Germany

4. Faculty of Medicine University of Cologne, Pediatric Pulmonology, Allergology and Cystic Fibrosis Center, Children's Hospital Cologne Germany

Abstract

AbstractInhalation therapy represents the standard of care in children, adolescents as well as in young, middle‐aged and geriatric adults with asthma or chronic obstructive pulmonary disease. However, there are only few recommendations for the choice of inhalation devices, which consider both, age‐specific limitations in young and geriatric patients. Transition concepts are lacking. In this narrative review, the available device technologies and the evidence for age‐specific problems are discussed.Pressurized metered‐dose inhalers may be favoured in patients who fulfill all cognitive, coordinative and manual power requirements. Breath‐actuated metered‐dose inhalers, soft‐mist inhalers or the use of add‐on devices such as spacers, face masks and valved holding chambers may be suitable for patients with mild to moderate impairments of these variables. In these cases, available resources of personal assistance by educated family members or caregivers should be used to allow metered‐dose inhaler therapy. Dry powder inhalers may be reserved for patients with a sufficient peak inspiratory flow and good cognitive and manual abilities. Nebulizers may be indicated in persons who are either unwilling or unable to use handheld inhaler devices. After initiation of a specific inhalation therapy, close monitoring is essential to reduce handling mistakes.An algorithm is developed that considers age and relevant comorbidities to support the decision‐making process for the choice of an inhaler device.

Publisher

Wiley

Subject

Genetics (clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Reference36 articles.

1. Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines

2. Global Initiative for Asthma.Global Strategy for Asthma Management and Prevention;2020. Full article available:www.ginasthma.com

3. Global Initiative for Chronic Obstructive Pulmonary Disease.Global Strategy for the Diagnosis Management and Prevention of Chronic Obstructive Pulmonary Disease;2021. Available from:www.goldcopd.org

4. Optimizing drug delivery in COPD: The role of inhaler devices

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3